# Sequentia Biotech, S.L.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sequentia-biotech-s-l

- Industry: Biotechnology
- Headquarters: Barcelona, Spain
- Website: www.sequentiabiotech.com/
- Total disclosed funding: $11M
- Latest round: Series A (Sep 27, 2024)
- Investors on record: 2

## About

Founded in 2013 and based in Barcelona, Spain, Sequentia Biotech, S.L. is a bioinformatics company that provides software and analytical services for processing and interpreting omics data. In September 2024, Sequentia Biotech, S.L. raised EUR 10 million in Series A funding led by Seventure Partners, with participation from European Innovation Council.

Sequentia Biotech's offerings include cloud-based bioinformatics platforms, custom software solutions tailored to specific data requirements, and consulting services for data analysis. The firm supports applications in genomics, transcriptomics, metagenomics, and epigenomics, with tools designed to manage and analyze large-scale biological datasets. These services are used in areas such as healthcare, agriculture, industry, and environmental research. The company also develops pipelines for next-generation sequencing data and offers support for projects requiring genome assembly and gene expression analysis.

The company intends to use the September 2024 funding to enhance bioinformatic solutions for clinical, industrial and research applications.

## Funding rounds

- Series A, Sep 27, 2024, $11M — Seventure Partners, European Innovation Council

## Investors

- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series A
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Series A